Retevmo 80 mg (Selpercatinib CAPSULE) 80 MG

Retevmo 80 mg capsules contain selpercatinib, a medication used to treat certain types of cancer. This oral medication is designed to target specific genetic mutations. Learn more about selpercatinib and its uses.

Strength

80 MG

Manufacturer / TM Owner

LOXO ONCOLOGY INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Retevmo 80 mg capsules are primarily used in the treatment of advanced cancers that harbor specific genetic alterations. Selpercatinib is often prescribed for patients with non-small cell lung cancer, thyroid cancer, and other solid tumors that exhibit RET gene fusions or mutations. This medication works by targeting the RET protein, which can help slow the growth and spread of cancer cells. Patients should consult their healthcare provider to determine if selpercatinib is suitable for their condition.

Side Effects

Common effects of Retevmo 80 mg capsules may include fatigue, diarrhea, and nausea. Some patients may also experience changes in taste, dry mouth, or constipation. These effects can vary in severity and duration. It is important to discuss any persistent or bothersome symptoms with a healthcare professional.

Precautions & Warnings

Retevmo 80 mg capsules should be handled with care and stored as directed. Patients should avoid breaking or crushing the capsules unless instructed to do so by a healthcare provider. It is important to follow the prescribed dosage and administration instructions to minimize the risk of adverse effects. Pregnant women or those planning to become pregnant should consult their healthcare provider before starting selpercatinib.

Avoid Interactions

Selpercatinib may interact with certain medications, including those that are metabolized by the liver's CYP3A enzyme system. Patients should inform their healthcare provider about all medications they are taking, including over-the-counter drugs, supplements, and herbal products. Alcohol consumption should be discussed with a healthcare provider, as it may affect the efficacy or safety of selpercatinib.

Frequently Asked Questions

Retevmo 80 mg capsules are used to treat certain types of cancer that have specific genetic mutations, such as non-small cell lung cancer and thyroid cancer.

Retevmo 80 mg capsules are taken orally, typically with or without food. Patients should follow their healthcare provider's instructions for dosage and administration.

Common side effects of Retevmo 80 mg may include fatigue, diarrhea, nausea, changes in taste, dry mouth, and constipation.

Selpercatinib may interact with certain medications, so patients should inform their healthcare provider about all medications they are taking.

Pregnant women or those planning to become pregnant should consult their healthcare provider before starting selpercatinib.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.